Skip to main content
Erschienen in: Clinical Oral Investigations 6/2016

05.10.2015 | Original Article

Effects of periodontal therapy on serum lipid profile and proinflammatory cytokines in patients with hyperlipidemia: a randomized controlled trial

verfasst von: Yong-Wei Fu, Xiang-Xin Li, Hong-Zhi Xu, Yong-Qing Gong, Yan Yang

Erschienen in: Clinical Oral Investigations | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to evaluate whether periodontal treatment in patients with periodontitis and hyperlipidemia may have any influence on plasma lipids and pro-inflammatory cytokine levels.

Material and methods

We randomly assigned 109 patients with hyperlipidemia and chronic periodontitis into group 1 (n = 55) and group 2 (n = 54). Patients in group 1 underwent a standard cycle of supragingival mechanical scaling and polishing. Patients in group 2 underwent the adjunctive full-mouth intensive removal of subgingival dental plaque biofilms with the use of scaling and root planning. Periodontal parameters, total cholesterol (TC), triglyceride (TRG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), tumor necrosis factor-alpha (TNF-α), interleukin(IL)-1β(IL-1β), and IL-6 were evaluated before treatment and 2 and 6 months after treatment.

Results

Two and 6 months after treatment, TRG levels were significantly lower in group 2 than in group 1 (P < 0.05), and the levels of HDL-C were significantly higher (P < 0.05). Two and 6 months after therapy, the levels of TNF-α were significantly lower in group 2 than in group 1 (P < 0.05), as were the levels of IL-1β (P < 0.001) and IL-6 (P < 0.001).

Conclusions

Intensive periodontal treatment of participants with hyperlipidemia and chronic periodontitis improved serum lipid levels and decreased circulating pro-inflammatory cytokine levels.

Clinical relevance

This study showed that intensive treatment of periodontitis results in an improvement in serum lipid levels and a decrease in serum proinflammatory cytokine levels in patients with periodontitis and hyperlipidemia. These findings may contribute to present knowledge that periodontal therapy may be beneficial for individuals with hyperlipidemia.
Literatur
1.
Zurück zum Zitat Sniderman AD, Furberg CD (2008) Age as a modifiable risk factor for cardiovascular disease. Lancet 371:1547–1549CrossRefPubMed Sniderman AD, Furberg CD (2008) Age as a modifiable risk factor for cardiovascular disease. Lancet 371:1547–1549CrossRefPubMed
2.
Zurück zum Zitat Satoh H, Tomita K, Fujii S, Kishi R, Tsutsui H (2009) Lower high-density lipoprotein cholesterol is a significant and independent risk for coronary artery disease in Japanese men. J Atheroscler Thromb 16:792–798CrossRefPubMed Satoh H, Tomita K, Fujii S, Kishi R, Tsutsui H (2009) Lower high-density lipoprotein cholesterol is a significant and independent risk for coronary artery disease in Japanese men. J Atheroscler Thromb 16:792–798CrossRefPubMed
3.
Zurück zum Zitat Graves DT (1999) The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28:482–490CrossRefPubMed Graves DT (1999) The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 28:482–490CrossRefPubMed
4.
Zurück zum Zitat Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A et al (2009) The American Journal of Cardiology and Journal of Periodontology Editors’ Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 104:59–68CrossRefPubMed Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A et al (2009) The American Journal of Cardiology and Journal of Periodontology Editors’ Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 104:59–68CrossRefPubMed
5.
Zurück zum Zitat Andriankaja OM, Genco RJ, Dorn J, Dmochowski J, Hovey K et al (2007) Periodontal disease and risk of myocardial infarction: the role of gender and smoking. Eur J Epidemiol 22:699–705CrossRefPubMed Andriankaja OM, Genco RJ, Dorn J, Dmochowski J, Hovey K et al (2007) Periodontal disease and risk of myocardial infarction: the role of gender and smoking. Eur J Epidemiol 22:699–705CrossRefPubMed
6.
Zurück zum Zitat Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154:830–837CrossRefPubMed Bahekar AA, Singh S, Saha S, Molnar J, Arora R (2007) The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 154:830–837CrossRefPubMed
7.
Zurück zum Zitat Katz J, Chaushu G, Sharabi Y (2001) On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 28:865–868CrossRefPubMed Katz J, Chaushu G, Sharabi Y (2001) On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 28:865–868CrossRefPubMed
8.
Zurück zum Zitat Katz J, Flugelman MY, Goldberg A, Heft M (2002) Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 73:494–500CrossRefPubMed Katz J, Flugelman MY, Goldberg A, Heft M (2002) Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 73:494–500CrossRefPubMed
9.
Zurück zum Zitat Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE (2003) Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71:6012–6018CrossRefPubMedPubMedCentral Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE (2003) Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71:6012–6018CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Iacopino AM, Cutler CW (2000) Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71:1375–1384CrossRefPubMed Iacopino AM, Cutler CW (2000) Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. J Periodontol 71:1375–1384CrossRefPubMed
11.
Zurück zum Zitat D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS (2005) Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84:269–273CrossRefPubMed D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS (2005) Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 84:269–273CrossRefPubMed
12.
Zurück zum Zitat Llambés F, Silvestre FJ, Hernández-Mijares A, Guiha R, Caffesse R (2008) The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus. Clin Oral Investig 12:337–343CrossRefPubMed Llambés F, Silvestre FJ, Hernández-Mijares A, Guiha R, Caffesse R (2008) The effect of periodontal treatment on metabolic control of type 1 diabetes mellitus. Clin Oral Investig 12:337–343CrossRefPubMed
13.
Zurück zum Zitat Almaghlouth AA, Cionca N, Cancela JA, Décaillet F, Courvoisier DS et al (2014) Effect of periodontal treatment on peak serum levels of inflammatory markers. Clin Oral Investig 18:2113–2121CrossRefPubMed Almaghlouth AA, Cionca N, Cancela JA, Décaillet F, Courvoisier DS et al (2014) Effect of periodontal treatment on peak serum levels of inflammatory markers. Clin Oral Investig 18:2113–2121CrossRefPubMed
14.
Zurück zum Zitat Lösche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T et al (2005) Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 32:640–644CrossRefPubMed Lösche W, Marshal GJ, Apatzidou DA, Krause S, Kocher T et al (2005) Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 32:640–644CrossRefPubMed
15.
Zurück zum Zitat Pejcic A, Kesic L, Brkic Z, Pesic Z, Mirkovic D (2011) Effect of periodontal treatment on lipoproteins levels in plasma in patients with periodontitis. South Med J 104:547–552CrossRefPubMed Pejcic A, Kesic L, Brkic Z, Pesic Z, Mirkovic D (2011) Effect of periodontal treatment on lipoproteins levels in plasma in patients with periodontitis. South Med J 104:547–552CrossRefPubMed
16.
Zurück zum Zitat Duan JY, Ou-Yang XY, Zhou YX (2009) Effect of periodontal initial therapy on the serum level of lipid in the patients with both periodontitis and hyperlipidemia. Beijing Da Xue Xue Bao 41:36–39PubMed Duan JY, Ou-Yang XY, Zhou YX (2009) Effect of periodontal initial therapy on the serum level of lipid in the patients with both periodontitis and hyperlipidemia. Beijing Da Xue Xue Bao 41:36–39PubMed
17.
Zurück zum Zitat Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrtover MD et al (2007) Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J 100:686–691CrossRefPubMed Oz SG, Fentoglu O, Kilicarslan A, Guven GS, Tanrtover MD et al (2007) Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J 100:686–691CrossRefPubMed
18.
Zurück zum Zitat Fentoğlu Ö, Köroğlu BK, Hiçyılmaz H, Sert T, Özdem M et al (2011) Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 38:8–16CrossRefPubMed Fentoğlu Ö, Köroğlu BK, Hiçyılmaz H, Sert T, Özdem M et al (2011) Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. J Clin Periodontol 38:8–16CrossRefPubMed
19.
Zurück zum Zitat Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M et al (2003) Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 74:1231–1236CrossRefPubMed Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M et al (2003) Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 74:1231–1236CrossRefPubMed
20.
Zurück zum Zitat D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM et al (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160CrossRefPubMed D’Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM et al (2004) Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 83:156–160CrossRefPubMed
21.
Zurück zum Zitat Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MC, de Souza AM et al (2009) Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602CrossRefPubMed Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MC, de Souza AM et al (2009) Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602CrossRefPubMed
22.
Zurück zum Zitat Vidal F, Figueredo CM, Cordovil I, Fischer RG (2009) Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80:786–791CrossRefPubMed Vidal F, Figueredo CM, Cordovil I, Fischer RG (2009) Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80:786–791CrossRefPubMed
23.
Zurück zum Zitat Liu K, Meng H, Lu R, Xu L, Zhang L et al (2010) Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D(3) and interleukin-1 beta in patients with aggressive periodontitis. J Periodontol 81:260–266CrossRefPubMed Liu K, Meng H, Lu R, Xu L, Zhang L et al (2010) Initial periodontal therapy reduced systemic and local 25-hydroxy vitamin D(3) and interleukin-1 beta in patients with aggressive periodontitis. J Periodontol 81:260–266CrossRefPubMed
24.
Zurück zum Zitat Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N et al (2010) The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 81:1118–1123CrossRefPubMed Shimada Y, Komatsu Y, Ikezawa-Suzuki I, Tai H, Sugita N et al (2010) The effect of periodontal treatment on serum leptin, interleukin-6, and C-reactive protein. J Periodontol 81:1118–1123CrossRefPubMed
25.
Zurück zum Zitat Ide M, Jagdev D, Coward PY, Crook M, Barclay GR et al (2004) The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 75:420–428CrossRefPubMed Ide M, Jagdev D, Coward PY, Crook M, Barclay GR et al (2004) The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 75:420–428CrossRefPubMed
26.
Zurück zum Zitat Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T et al (2005) Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 40:53–58CrossRefPubMed Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T et al (2005) Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 40:53–58CrossRefPubMed
27.
Zurück zum Zitat Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R et al (2009) Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 36:287–294CrossRefPubMedPubMedCentral Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R et al (2009) Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol 36:287–294CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26:230–242CrossRefPubMed Page RC (1991) The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 26:230–242CrossRefPubMed
29.
Zurück zum Zitat Page RC, Kornman KS (1997) The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14:9–11CrossRefPubMed Page RC, Kornman KS (1997) The pathogenesis of human periodontitis: an introduction. Periodontol 2000 14:9–11CrossRefPubMed
Metadaten
Titel
Effects of periodontal therapy on serum lipid profile and proinflammatory cytokines in patients with hyperlipidemia: a randomized controlled trial
verfasst von
Yong-Wei Fu
Xiang-Xin Li
Hong-Zhi Xu
Yong-Qing Gong
Yan Yang
Publikationsdatum
05.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Oral Investigations / Ausgabe 6/2016
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-015-1621-2

Weitere Artikel der Ausgabe 6/2016

Clinical Oral Investigations 6/2016 Zur Ausgabe

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.